BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Thompson JR. Emerging therapeutic options for the management of hepatitis C infection. World J Gastroenterol 2014; 20(23): 7079-7088 [PMID: 24966581 DOI: 10.3748/wjg.v20.i23.7079]
URL: https://www.wjgnet.com/1007-9327/full/v20/i23/7079.htm
Number Citing Articles
1
Amit Khatri, Sandeep Dutta, Thomas C. Marbury, Richard A. Preston, Lino Rodrigues, Haoyu Wang, Walid M. Awni, Rajeev M. Menon. Pharmacokinetics and Tolerability of Anti-Hepatitis C Virus Treatment with Ombitasvir, Paritaprevir, Ritonavir, with or Without Dasabuvir, in Subjects with Renal ImpairmentClinical Pharmacokinetics 2017; 56(2): 153 doi: 10.1007/s40262-016-0429-9
2
Bruno Pozzetto, Meriam Memmi, Olivier Garraud, Xavier Roblin, Philippe Berthelot. Health care-associated hepatitis C virus infectionWorld Journal of Gastroenterology 2014; 20(46): 17265-17278 doi: 10.3748/wjg.v20.i46.17265
3
Sven Mensing, Akshanth R. Polepally, Denise König, Amit Khatri, Wei Liu, Thomas J. Podsadecki, Walid M. Awni, Rajeev M. Menon, Sandeep Dutta. Population Pharmacokinetics of Paritaprevir, Ombitasvir, Dasabuvir, Ritonavir, and Ribavirin in Patients with Hepatitis C Virus Genotype 1 Infection: Combined Analysis from 9 Phase 1b/2 StudiesThe AAPS Journal 2016; 18(1): 270 doi: 10.1208/s12248-015-9846-1
4
Matthew Ronan. Hepatitis C in Hospital MedicineHospital Medicine Clinics 2015; 4(2): 163 doi: 10.1016/j.ehmc.2014.11.003
5
Cássio Marques Perlin, Vinicius Lins Ferreira, Helena Hiemisch Lobo Borba, Astrid Wiens, Cláudia Alexandra Pontes Ivantes, Luana Lenzi, Roberto Pontarolo. Quality of life in Brazilian patients with treated or untreated chronic hepatitis CRevista do Instituto de Medicina Tropical de São Paulo 2017; 59(0) doi: 10.1590/s1678-9946201759081
6
Akshanth R. Polepally, Sven Mensing, Amit Khatri, Denise Beck, Wei Liu, Walid M. Awni, Rajeev M. Menon, Sandeep Dutta. Dose- and Formulation-Dependent Non-Linear Pharmacokinetic Model of Paritaprevir, a Protease Inhibitor for the Treatment of Hepatitis C Virus Infection: Combined Analysis from 12 Phase I StudiesClinical Pharmacokinetics 2016; 55(9): 1091 doi: 10.1007/s40262-016-0385-4
7
N.A. Meanwell. Comprehensive Medicinal Chemistry III2017; : 553 doi: 10.1016/B978-0-12-409547-2.12406-0